Replies to post #1249 on MEI Pharma, Inc. (MEIP)

[bladerunner1717]

This is a $20-30 stock, if Pracinostat succeeds in AML. If it succeeds in MDS, it will go much higher.

The P13K Delta inhibitor has promise as well.

On a risk/reward basis, I regard MEIP as the most undervalued stock in all of biotech.


Bladerunner